Cargando…

Modeling HIV Pre-Exposure Prophylaxis

Pre-exposure prophylaxis (PrEP) has emerged as a promising strategy for preventing the transmission of HIV. Although only one formulation is currently approved for PrEP, research into both new compounds and new delivery systems for PrEP regimens offer intriguing challenges from the perspective of ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Straubinger, Thomas, Kay, Katherine, Bies, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005100/ https://www.ncbi.nlm.nih.gov/pubmed/32082142 http://dx.doi.org/10.3389/fphar.2019.01514

Ejemplares similares

Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
por: von Kleist, Max, et al.
Publicado: (2020)

Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure
por: Blumenthal, Jill, et al.
Publicado: (2019)

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach
por: Mallayasamy, Surulivelrajan, et al.
Publicado: (2019)

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
por: Pyra, Maria, et al.
Publicado: (2019)

Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis
por: Lal, Luxi, et al.
Publicado: (2019)

Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011)

Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy
por: Scott, Rachel K., et al.
Publicado: (2023)

Prescribing pre-exposure prophylaxis for HIV
por: Bloch, Mark
Publicado: (2020)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized Trials
por: Lazarus, Gilbert, et al.
Publicado: (2021)

Pre-exposure prophylaxis for HIV: effective and underused
por: Hempel, Amanda, et al.
Publicado: (2022)

Pre-exposure prophylaxis for prevention of HIV infection
por: Lee, Joseph Wei En, et al.
Publicado: (2023)

Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments
por: Perazzolo, Simone, et al.
Publicado: (2020)

Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
por: Vanbaelen, Thibaut, et al.
Publicado: (2022)

Pre-exposure prophylaxis against HIV: pros and cons
por: Wainberg, Mark
Publicado: (2012)

Top Questions in ID: Pre-exposure Prophylaxis for HIV
por: Krakower, Douglas S, et al.
Publicado: (2017)

Defining the HIV pre-exposure prophylaxis care continuum
por: Nunn, Amy S., et al.
Publicado: (2017)

Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
por: Tetteh, Raymond A., et al.
Publicado: (2017)

Pre- and post-sexual exposure prophylaxis of HIV: An update
por: Marfatia, Yogesh S., et al.
Publicado: (2017)

Pre- and post-sexual exposure prophylaxis of HIV: An update
por: Siddiqui, Gulnaz Fatima, et al.
Publicado: (2019)

Efficacy and Safety of Oral TDF-Based Pre-exposure Prophylaxis for Men Who Have Sex With Men: A Systematic Review and Meta-Analysis
por: Huang, Xiaojie, et al.
Publicado: (2018)

Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic
por: Prins, Henrieke, et al.
Publicado: (2023)

2560. Assessing Resident Perspectives on Prescribing Pre-Exposure Prophylaxis for HIV
por: Shallal, Anita, et al.
Publicado: (2019)

A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
por: Siegler, Aaron J., et al.
Publicado: (2020)

Adolescent pre-exposure prophylaxis for HIV prevention: current perspectives
por: Machado, Daisy Maria, et al.
Publicado: (2017)

Pre-exposure Prophylaxis as HIV Prevention in High Risk Adolescents
por: Gray, Megan E., et al.
Publicado: (2018)

A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
por: Bailey, Jennifer L., et al.
Publicado: (2017)

Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea
Publicado: (2017)

Pre-exposure prophylaxis for HIV prevention in women: current perspectives
por: Flash, Charlene A, et al.
Publicado: (2017)

Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV
por: Ballreich, Jeromie, et al.
Publicado: (2022)

Maintaining access to HIV pre-exposure prophylaxis in a pandemic: A service evaluation of telephone-based pre-exposure prophylaxis provision
por: Henderson, Lindsay, et al.
Publicado: (2022)

1523 Attitudes and Interest Toward HIV Pre-Exposure Prophylaxis Among Participants Using HIV Non-Occupational Post-Exposure Prophylaxis
por: Jain, Sachin, et al.
Publicado: (2014)

Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
por: Kasaie, Parastu, et al.
Publicado: (2019)

Mathematical Modeling of HIV Prevention Measures Including Pre-Exposure Prophylaxis on HIV Incidence in South Korea
por: Kim, Sun Bean, et al.
Publicado: (2014)

Pre-clinical evaluation of antiproteases as potential candidates for HIV-1 pre-exposure prophylaxis
por: Herrera, Carolina, et al.
Publicado: (2022)

Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells
por: Miao, Xin, et al.
Publicado: (2016)

Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins
por: Rivera, Adovich S., et al.
Publicado: (2023)

HIV diagnoses in Australia fall as clinicians embrace pre-exposure prophylaxis
por: Medland, Nicholas A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6f6mp7ufj3qkdetn161hvoop3n